Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00677222 · ClinicalTrials.gov registry record · Phase 1
Safety Study of AMI MultiStem® to Treat Heart Attacks
A Phase 1 study, sponsored by Healios K.K..
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00677222: Completed Phase 1 study, sponsored by Healios K.K..
NCT00677222 is a Phase 1 study that has completed, run by Healios K.K.. The registered enrollment target is 25 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00677222, a Phase 1 study, has completed, sponsored by Healios K.K..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if escalating doses of AMI MultiStem® delivered by catheter can safely be given to patients that have had a recent heart attack treated with stent implantation.
Interventions
- BIOLOGICAL AMI MultiStem®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
What the finished NCT00677222 record still lists
NCT00677222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which AMI MultiStem® is the first listed.
NCT00677222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00677222 about?
NCT00677222 is a clinical study titled "Safety Study of AMI MultiStem® to Treat Heart Attacks". The purpose of this study is to determine if escalating doses of AMI MultiStem® delivered by catheter can safely be given to patients that have had a recent heart attack treated with stent implantation.
What is the current status of trial NCT00677222?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2008-05. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00677222?
The interventions under investigation include: AMI MultiStem® (BIOLOGICAL).
Who is sponsoring clinical trial NCT00677222?
This trial is sponsored by Healios K.K., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00677222's enrollment target sits among peer trials
25 1495th of 2000 higher than 481 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia